Vol 11, Supp. A (2020)

Date published: 2021-01-07

Table of Contents

open access

EDITORIAL

Editorial

Iwona Hus

Editorial

DOI: 10.5603/Hem.2020.0021
CASE REPORTS

Loss of complete cytogenetic response after nilotinib discontinuation

Tomasz Sacha, Joanna Wącław

Case report

DOI: 10.5603/Hem.2020.0016

Successful nilotinib cessation after imatinib therapy failure

Joanna Wącław, Tomasz Sacha

Case report

DOI: 10.5603/Hem.2020.0019

Successful nilotinib cessation after imatinib therapy intolerance

Joanna Wącław, Tomasz Sacha

Case report

DOI: 10.5603/Hem.2020.0020

Rapid molecular recurrence after nilotinib therapy cessation

Joanna Wącław, Tomasz Sacha

Case report

DOI: 10.5603/Hem.2020.0017

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.